New Editor-in-Chief Announcement
The European Journal of Hybrid Imaging is pleased to announce Prof Dr Francesco Giammarile as the new Editor-in-Chief of the journal, effective from January 2019.
Prof Giammarile is a Professor in the academic Nuclear Medicine Department of University Hospital Lyon and a Senior Technical Officer at the International Atomic Energy Agency. He is also the EANM Congress Chair for 2017-2019.
Prof. Arturo Chiti, Humanitas University, Italy, became the first Editor-in-Chief of the European Journal of Hybrid Imaging in 2016, and we thank him for his immense engagement in ensuring an outstanding start for the newest journal of the EJNMMI Journal Family. We welcome him to his new role as the Editor-in-Chief of the European Journal of Nuclear Medicine and Molecular Imaging.
To find out more, please see the announcement editorial by Profs Chiti and Giammarile, "European Journal of Hybrid Imaging: the journey continues".
For more information on recent developments in the EJNMMI Journal Family, as well as the latest research, please visit the Journal Family Gateway.
Aims and scope
Focuses on clinical and research studies conducted with hybrid or multimodality imaging techniques.
Contents include original research articles, short communications, case reports, reviews, guidelines, editorials, and letters.
The European Journal of Hybrid Imaging publishes new basic and clinical research in the field of imaging, conducted with hybrid or multimodality techniques.
Regular features include original research articles, brief communications on novel preliminary approaches, interesting case reports, reviews, guidelines, editorials, and letters to the editor. Educational articles on hybrid imaging modalities and their pre-clinical and clinical applications are also accepted. Review articles provide updates on current applications and issues in the clinical application of hybrid imaging. Guidelines, published by experts from different clinical disciplines, include the clinical, educational and procedural recommendations on the use of hybrid imaging.
The unique characteristic of this journal is the focus on hybrid and multimodality imaging technology in different clinical and research fields: oncology, neurology, cardiology, orthopedics, infection imaging.
EJNMMI Journal Family
Discover featured content, editor’s highlights, and the latest research via our Gateway to the EJNMMI Journal Family.
Check if your institution is a BMC member
More than 500 institutions have partnered with BMC through the membership program. As an affiliated Author from a member institution, you may be entitled to submit your manuscript without paying the article processing charge (APC) or with a discount. Check here if your institution is a member!
EANM Sponsorship Programme
The EANM Board decided to allocate funds to a dedicated Publication Fee Sponsorship Programme for the entire EJNMMI journal family. Through this programme, the EANM will cover the charges that arise for selected open choice publications in the EJNMMI and open access publications in EJNMMI Research, EJNMMI Physics, EJNMMI Radiopharmacy and Chemistry as well as the European Journal of Hybrid Imaging. Find out more.
Imaging is developing at an exceptional pace in these years and it is confirming its role in the management of patients affected by several diseases.
Different imaging modalities are used in combination in research and clinical practice, in order to evaluate different characteristics of a particular organ or district. The combination of two imaging modalities, typically PET and CT, or SPECT and CT or PET and MR, is referred to as hybrid imaging.
Hybrid imaging represents the great majority of the daily workflow in several imaging departments in the world. Also, hybrid imaging is used to study biological processes with dedicated animal scanners in research applications.
The European Journal of Hybrid Imaging was created as a platform to publish papers focussed on the use of hybrid and multimodality imaging in clinical practice, clinical trials and pre-clinical research. EJHI is going to be an active part of the family of EANM journals, integrating its role with the main journal, EJNMMI, and the others journals of the family: EJNMMI Research, EJNMMI Physics and EJNMMI Radiopharmacy and Chemistry.
A fast and effective peer review process, in line with the characteristics of the EJNMMI family of journals, has been set up within the Springer Nature platform and ensures a rapid appraisal of manuscripts. The editorial board has been formed thanks to the availability of skilled and enthusiastic experts in hybrid imaging that will guide the EJHI throughout its journey in the world of scientific journals.
The open access model offers a fast and reliable way to disseminate knowledge and can be supported with several funding schemes when authors have no resources for publication.
Besides original articles, the EJHI is aimed at publishing short communications, case reports and reviews. Comments and ideas can be shared within the scientific community with editorials and letters to the Editor.
We are confident that the EJHI will actively contribute to creating a bridge between the different modalities that are used in imaging, and will facilitate their use in the scientific community.
2017 Journal Metrics
30 days to first decision for reviewed manuscripts only
30 days to first decision for all manuscripts
121 days from submission to acceptance
27 days from acceptance to publication
- ISSN: 2510-3636